<DOC>
	<DOCNO>NCT00222352</DOCNO>
	<brief_summary>In randomize , control clinical trial , point-of care test bedside use cardiac biomarker troponin I ED patient possible ACS compare traditional test assay myocardial necrosis obtain central laboratory . Our hypothesis : point-of-care test troponin I decrease time disposition patient possible ACS emergency set decrease time require administer appropriate therapy patient .</brief_summary>
	<brief_title>Diagnosis Treatment ACS ED : The Impact Rapid Bedside cTnI Testing Outcomes</brief_title>
	<detailed_description>Cardiac troponin I routinely use emergency department risk stratification tool detect myocardial necrosis patient possible acute coronary syndrome . It hypothesis bedside , point-of-care test TnI ED decrease time need disposition patient home ED send cardiac catheterization laboratory intensive care set . Similarly , point-of-care test ED decrease time require deliver anti-platelet drug aspirin glycoprotein IIb/IIIa inhibitor anti-thrombin agent heparin high risk patient find positive TnI test . This evaluated randomized , control clinical trial 2000 patient . Half test perform ED bedside ( point-of-care ) half receive usual lab result obtain central lab ( typically require 1.5-2 hour return ) .</detailed_description>
	<mesh_term>Angina , Unstable</mesh_term>
	<criteria>Age great equal 21 year old Chest pain symptom lead draw cardiac biomarkers possible ACS diagnosis Presentation chest pain presence tachydysrhythmia ( ventricular tachycardia , supraventricular tachycardia , rapid atrial fibrillation ) Presentation ECG diagnostic STEMI</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>Unstable Angina</keyword>
	<keyword>Non-ST-segment Myocardial Infarction</keyword>
	<keyword>Myocardial Necrosis</keyword>
	<keyword>Troponin I</keyword>
</DOC>